---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-019033"
form_type: "8-K"
ticker: "OPK"
cik: "0000944809"
company_name: "OPKO HEALTH, INC."
filed_at: "2023-06-30T23:59:59+00:00"
generated_at: "2026-06-13T14:33:42.095875+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# OPKO subsidiary BRH cuts revolver from $75M to $50M, extends maturity to Aug 2025/conditional

## Summary
- Aggregate revolving commitment reduced from $75M to $50M.
- Maturity extended from August 2024 to earlier of August 2025 or 90 days before maturity of any material OPKO-level debt.
- Interest rate benchmark switched from LIBOR to forward-looking term SOFR.
- Revised commitment fee rate; full terms to be filed in Q2 2023 10-Q.

## SEC filing metadata
- accession: 0001437749-23-019033
- form_type: 8-K
- ticker: OPK
- cik: 0000944809
- company_name: OPKO HEALTH, INC.
- filed_at: 2023-06-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/944809/000143774923019033/0001437749-23-019033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/944809/000143774923019033/opk20230630_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-019033
- JSON: https://secwatch.observer/filing/0001437749-23-019033.json
- Plain text: https://secwatch.observer/filing/0001437749-23-019033.txt

## Key facts
- Material Agreements
  OPKO HEALTH, INC. amended Waiver and Amendment No. 2 with JPMorgan Chase Bank, N.A., as administrative agent for the lenders (effective 2023-06-29).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: JPMorgan Chase Bank, N.A., as administrative agent for the lenders
  - Effective: 2023-06-29
  source text: On June 29, 2023, BioReference Health, LLC, a Delaware limited liability company (“ BRH ”), a subsidiary of OPKO Health, Inc. (the “ Company ”), together with the other parties thereto, entered into a Waiver and Amendment No. 2 (the “ Amendment ”) to the Amended and Restated Credit Agreement (the “ Amended Credit Agreement ”), dated as of August 30, 2021, by and among BRH, certain of its subsidiaries, as borrowers or guarantors, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent for the lenders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/944809/000143774923019033/0001437749-23-019033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.